InvestorsHub Logo

Blane

02/12/17 1:10 AM

#2072 RE: crazydrinker622 #2071

In about two weeks, we are expecting to have a quarterly meeting. We potentially could have more data and possibly a deal regarding HBV, if the data is good. There is potential for AMD deal in the future, and potential callimune HIV data as well. I have learned that if Callimune starts a phase III trial, there is possibility of 550k payment if it is started before the graham patent expires.

Hope that helps!